AIM ImmunoTech Inc (AIM)
0.2117
+0.01
(+5.85%)
USD |
NYAM |
Nov 21, 16:00
0.2117
0.00 (0.00%)
Pre-Market: 09:19
AIM ImmunoTech Shares Outstanding: 63.71M for Nov. 13, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
November 13, 2024 | 63.71M |
November 11, 2024 | 63.71M |
October 28, 2024 | 63.71M |
October 01, 2024 | 63.32M |
September 30, 2024 | 58.67M |
September 03, 2024 | 57.14M |
August 14, 2024 | 57.14M |
August 12, 2024 | 57.14M |
July 25, 2024 | 57.14M |
July 24, 2024 | 57.14M |
July 10, 2024 | 57.14M |
June 30, 2024 | 57.14M |
June 03, 2024 | 57.14M |
May 30, 2024 | 51.50M |
May 13, 2024 | 51.28M |
April 26, 2024 | 50.89M |
April 12, 2024 | 50.75M |
March 31, 2024 | 50.25M |
March 28, 2024 | 50.24M |
March 27, 2024 | 49.90M |
December 31, 2023 | 49.10M |
November 12, 2023 | 48.84M |
October 02, 2023 | 48.80M |
September 30, 2023 | 48.80M |
August 11, 2023 | 48.67M |
Date | Value |
---|---|
June 30, 2023 | 48.42M |
May 10, 2023 | 48.41M |
April 18, 2023 | 48.41M |
March 31, 2023 | 48.41M |
March 28, 2023 | 48.41M |
March 24, 2023 | 48.41M |
December 31, 2022 | 48.08M |
November 09, 2022 | 48.08M |
September 30, 2022 | 48.08M |
September 09, 2022 | 48.05M |
August 11, 2022 | 48.05M |
June 30, 2022 | 48.05M |
May 10, 2022 | 48.05M |
March 31, 2022 | 47.99M |
March 25, 2022 | 47.99M |
January 19, 2022 | 46.50M |
December 31, 2021 | 47.99M |
November 08, 2021 | 47.85M |
September 30, 2021 | 47.85M |
August 16, 2021 | 47.85M |
August 11, 2021 | 47.85M |
August 10, 2021 | 47.85M |
June 30, 2021 | 47.83M |
May 12, 2021 | 47.83M |
March 31, 2021 | 47.83M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
10.39M
Minimum
Dec 31 2019
63.71M
Maximum
Oct 28 2024
46.28M
Average
48.05M
Median
Aug 11 2022
Shares Outstanding Benchmarks
Perspective Therapeutics Inc | 67.59M |
Protalix BioTherapeutics Inc | 73.63M |
Electromed Inc | 8.458M |
Xtant Medical Holdings Inc | 139.01M |
Armata Pharmaceuticals Inc | 36.18M |